Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors

Por Vergote, Ignace, Leamon, Christopher P.
Publicado no Ther Adv Med Oncol (2015)

Ovarian cancer and the immune system

Por Baert, Thaïs, Vergote, Ignace, Coosemans, An
Publicado no Gynecol Oncol Rep (2017)

Dendritic cell-based immunotherapy in ovarian cancer

Por Coosemans, An, Vergote, Ignace, Van Gool, Stefaan W
Publicado em 2013

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer

Por Baert, Thaïs, Verschuere, Tina, Van Hoylandt, Anaïs, Gijsbers, Rik, Vergote, Ignace, Coosemans, An
Publicado no J Immunother Cancer (2015)

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome

Por Maleux, Geert, Indesteege, Inge, Laenen, Annouschka, Verslype, Chris, Vergote, Ignace, Prenen, Hans
Publicado no Radiol Oncol (2016)

Dendritic cell immunotherapy in uterine cancer

Por Coosemans, An, Tuyaerts, Sandra, Vanderstraeten, Anke, Vergote, Ignace, Amant, Frédéric, Van Gool, Stefaan W
Publicado em 2014

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

Por Van Gorp, Toon, Cadron, Isabelle, Daemen, Anneleen, De Moor, Bart, Waelkens, Etienne, Vergote, Ignace
Publicado em 2012

Reactive Nodular Fibrous Pseudotumor: Case Report and Review of the Literature

Por Salihi, Rawand, Moerman, Philippe, Timmerman, Dirk, Van Schoubroeck, Dominique, Op de beeck, Katya, Vergote, Ignace
Publicado em 2014

Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course

Por Coosemans, An, Decoene, Judit, Baert, Thaïs, Laenen, Annouschka, Kasran, Ahmad, Verschuere, Tina, Seys, Sven, Vergote, Ignace
Publicado no Oncoimmunology (2015)

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

Por van Schooneveld, Eleni, Wildiers, Hans, Vergote, Ignace, Vermeulen, Peter B, Dirix, Luc Y, Van Laere, Steven J
Publicado no Breast Cancer Res (2015)

Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor

Por Van Keirsbilck, Joachim, Riphagen, Ine, Struyven, Hans, Van den Eeckhout, Andre, Cornelis, Ann, Neven, Patrick, Amant, Frederic, Vergote, Ignace
Publicado em 2008

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report

Por Amant, Frédéric, Van Calsteren, Kristel, Debiec-Rychter, Maria, Heyns, Liesbeth, De Beeck, Katya Op, Sagaert, Xavier, Bollen, Bart, Vergote, Ignace
Publicado em 2010

Increased expression of placental growth factor in high-grade endometrial carcinoma

Por COENEGRACHTS, LIEVE, SCHRAUWEN, STEFANIE, VAN BREE, RITA, DESPIERRE, EVELYN, LUYTEN, CATHERINE, JONCKX, BART, STASSEN, JEAN MARIE, VERGOTE, IGNACE, AMANT, FRÉDÉRIC
Publicado em 2013

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium

Por Braicu, Elena Ioana, Van Gorp, Toon, Nassir, Mani, Richter, Rolf, Chekerov, Radoslav, Gasimli, Khayal, Timmerman, Dirk, Vergote, Ignace, Sehouli, Jalid
Publicado em 2014

Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation

Por Gevaert, Olivier, De Smet, Frank, Van Gorp, Toon, Pochet, Nathalie, Engelen, Kristof, Amant, Frederic, De Moor, Bart, Timmerman, Dirk, Vergote, Ignace
Publicado em 2008

Laparoscopic versus robotic-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review

Por Callewaert, Geertje, Bosteels, Jan, Housmans, Susanne, Verguts, Jasper, Van Cleynenbreugel, Ben, Van der Aa, Frank, De Ridder, Dirk, Vergote, Ignace, Deprest, Jan
Publicado no Gynecol Surg (2016)

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Por Lindemann, Kristina, Malander, Susanne, Christensen, Rene D, Mirza, Mansoor R, Kristensen, Gunnar B, Aavall-Lundqvist, Elisabeth, Vergote, Ignace, Rosenberg, Per, Boman, Karin, Nordstrøm, Britta
Publicado em 2014

HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer – a study of the OVCAD Consortium

Por Braicu, Elena Ioana, Luketina, Hrvoje, Richter, Rolf, Cacsire Castillo-Tong, Dan, Lambrechts, Sandrina, Mahner, Sven, Concin, Nicole, Mentze, Monika, Zeillinger, Robert, Vergote, Ignace, Sehouli, Jalid
Publicado em 2014

Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection

Por Lu, Jian-Feng, Rasmussen, Erik, Karlan, Beth Y., Vergote, Ignace B., Navale, Lynn, Kuchimanchi, Mita, Melara, Rebeca, Stepan, Daniel E., Weinreich, David M., Sun, Yu-Nien
Publicado em 2012

Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study

Por Michielsen, Katrijn L M, Vergote, Ignace, Dresen, Raphaëla, Op de Beeck, Katya, Vanslembrouck, Ragna, Amant, Frédéric, Leunen, Karin, Moerman, Philippe, Fieuws, Steffen, De Keyzer, Frederik, Vandecaveye, Vincent
Publicado no Br J Radiol (2016)